Gilead Sciences Inc buy Snowman
Start price
19.01.21
/
50%
€55.31
Target price
19.01.22
€67.00
Performance (%)
14.53%
End price
20.01.22
€60.94
Summary
This prediction ended on 20.01.22 with a price of €60.94. The prediction had a final performance of 14.53%. Dividends of €2.41 are taken into consideration when calculating the performance. Snowman has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Gilead Sciences Inc | -0.800% | -0.800% | -6.719% | 9.921% |
iShares Core DAX® | 3.054% | -1.396% | 15.789% | 12.675% |
iShares Nasdaq 100 | 4.389% | -5.391% | 29.906% | 39.325% |
iShares Nikkei 225® | 5.386% | -3.105% | 16.065% | 8.150% |
iShares S&P 500 | 2.955% | -3.011% | 25.903% | 37.650% |
According to Snowman what are the pros and cons of Gilead Sciences Inc for the foreseeable future?
Pros
Top 10 in its market
Good rating
Medium risks for its business
Future proof or reliable business model
Cons
Bad culture
Comments by Snowman for this prediction
In the thread Gilead Sciences Inc diskutieren
Buy mit Kursziel 68,0
Kursziel geändert auf 64,0
Kursziel geändert auf 67,0
In the thread Trading Gilead Sciences Inc
Die von Snowman gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Snowman for Gilead Sciences Inc
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€67.38
13.10.22
13.10.22
€46.00
13.10.23
13.10.23
9.44%
14.10.23
14.10.23
Top 10 in its market
Good rating
Medium risks for its business
Bad culture
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€66.92
13.10.22
13.10.22
-
-
13.10.22
13.10.22
Top 10 in its market
Good rating
Medium risks for its business
Bad culture
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€56.78
04.02.22
04.02.22
€46.00
04.02.23
04.02.23
18.67%
13.10.22
13.10.22
Top 10 in its market
Good rating
Medium risks for its business
Bad culture
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€48.17
18.12.20
18.12.20
€27.00
18.06.21
18.06.21
14.83%
19.01.21
19.01.21
Top 10 in its market
Good rating
Medium risks for its business
Bad culture